Home > Healthcare > Medical Devices > Implantable Devices > Coronary Stents Market

Coronary Stents Market Share

Report ID: GMI2966
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Coronary Stents Market Share

The market is characterized by the presence of several key global players, including Abbott Laboratories, Boston Scientific, Medtronic, and BIOTRONIK. These companies dominate the market with advanced product offerings such as drug-eluting stents, bioabsorbable stents, and cobalt-chromium alloy stents. The market is also seeing increasing competition from local manufacturers in emerging markets, which offer cost-effective solutions. Innovation, strategic partnerships, and mergers/acquisitions are central to the competition as companies aim to expand their product portfolios and geographic reach.

Coronary Stents Market Companies

Prominent players operating in the coronary stents industry include:

Abbott Laboratories
Andramed GmbH
B. Braun Melsungen
Biosensors International Group
Biotronik SE & Co. KG
Boston Scientific Corporation
Cook Medical
Elixir Medical Corporation
GENOSS
Medtronic
Meril Life Science
MicroPort Scientific Corporation
Sahajanand Laser Technology
Stryker Corporation
Terumo Corporation

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global coronary stents industry was valued at USD 7.5 billion in 2024 and is expected to grow at a 7.2% CAGR from 2025 to 2034, driven by the rising prevalence of cardiovascular diseases.

The drug-eluting stent segment generated USD 6.4 billion in 2024 due to their ability to significantly reduce restenosis by releasing medication that prevents excessive tissue growth.

The North America coronary stents market recorded USD 3 billion in 2024 and is anticipated to grow at a 6.4% CAGR between 2025 and 2034, driven by a high incidence of cardiovascular diseases.

Key players in the industry include Abbott Laboratories, Andramed GmbH, B. Braun Melsungen, Biosensors International Group, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, Elixir Medical Corporation, GENOSS, Medtronic, and Meril Life Science.